Association between type III collagen degradation and local tissue damage of a single joint
Objective: The development of disease-modifying drugs is limited by OA's heterogeneity and the challenge of defining clinical endpoints. Serological biomarkers are considered potential surrogate endpoints, but their contribution from single joints to systemic levels in OA patients is unclear. In thi...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2024-12-01
|
| Serie: | Osteoarthritis and Cartilage Open |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2665913124000943 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|